Screener
MiniMed Group MMED Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by MiniMed Group in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: MiniMed Group’s 10-K, filed June 29, 2026.
- Filed
- Jun 29, 2026, 12:09 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-045915
| (in millions) | April 24, 2026 | April 25, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $298 | $11 |
| Accounts receivable, less allowance for credit losses of $26 and $46, respectively | 200 | 570 |
| Due from Medtronic | 455 | — |
| Inventories | 341 | 311 |
| Other current assets | 54 | 48 |
| Total current assets | 1,348 | 939 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is MiniMed Group's cash & equivalents?
- MiniMed Group (MMED) reported cash & equivalents of $298M in Q2 2026.
- How has MiniMed Group's cash & equivalents changed year-over-year?
- MiniMed Group's cash & equivalents increased by 2609.1% year-over-year, from $11M to $298M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about MiniMed Group's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude